tfchemistry.com rapport :   Visitez le site

Données techniques du tfchemistry.com

Geo IP vous fournit comme la latitude, la longitude et l'ISP (Internet Service Provider) etc. informations. Notre service GeoIP a trouvé l'hôte tfchemistry.com.Actuellement, hébergé dans France et son fournisseur de services est Network Consulting .

the related websites

domaine	Titre
tfchemistry.com	about tfchem «

cosmetic-valley.com 

Analyse d'en-tête HTTP

Les informations d'en-tête HTTP font partie du protocole HTTP que le navigateur d'un utilisateur envoie à appelé Apache contenant les détails de ce que le navigateur veut et acceptera de nouveau du serveur Web.

DNS

HtmlToText

sirona biochem tfchem contact location careers a a a sirona about sirona management board of directors scientific advisory board tfchem about tfchem management team laboratory capabilities partners programs proprietary platform technology pipeline diabetes – sglt2 inhibitor skin lightening anti-aging protein inducers purchase purchase ipgmim contract services media & investors sirona news tfchem news (fr) events financial information investor & media kit 2017 proxy documents tfchem about tfchem management team partners tfchem laboratory capabilities à propos de tfchem about tfchem a subsidiary of sirona tfchem has a high degree of expertise in the field of carbohydrate and fluorine chemistry. the company has developed a unique know-how which combines these two technical domains in order to create new drug-candidates based on original carbohydrate mimics. the drug-discovery activity thus builds up the core of development of the company. tfchem uses the properties of fluorine atoms to develop new glycomimetic compounds through their glycomim® technology . using this technology, tfchem has become a leader in the area of fluorinated glycosides and their application as new, more potent and safer drugs. tfchem brings a unique solution to the severe drawbacks (stability and bioavailability) usually associated with carbohydrate-based drugs and thus allows the full exploitation of their therapeutic potential and the development of new drugs. tfchem develops and markets its glycomim® technology for pharmaceutical and biotechnology companies through licensing and strategical partnerships by offering in its portfolio : analogs of existing glycoconjugates. neo-glycosylation of active molecules new chemical entities (nce) fluoroglycosylated. tfchem’s proprietary chemistry technology can be applied to the development of several major pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. in addition, our carbohydrate chemistry expertise can be used to develop cosmetic and biological ingredients. see our cso, dr. deliencourt-godefroy, presenting at the adaptations to the polar area and biomimetism conference in france here . related information sirona biochem fact sheet 2016 sirona biochem investor presentation sirona biochem corporation - ceo letter to shareholders, dec 22, 2014 product development while carbohydrate-based molecules offer immense commercial potential, we are focusing on three programs at this time. news events twitter news sirona biochem announces cfda approval of sglt2 inhibitor for phase i clinical trial 12 jul 2018 sirona biochem to exhibit at the shanghai china beauty expo 2018 30 apr 2018 sirona biochem announces chief scientific officer to present at adaptations in polar environments and biomimicry 2 feb 2018 more news sirona news tfchem news (fr) social links sidebar twitter facebook linkedin youtube blog sign up to receive company information to be added to our mailing list, click here or send us an email here: info@sironabiochem.com events sirona annual general meeting 1500-1055 west georgia vancouver bc monday, december 18, 2017 – 10 am sirona biochem to present at cosmetic 360 in paris, france october 18-19, 2017 sirona biochem to attend the 2017 bio international conference in san diego june 19-22, 2017 @sironabiochem july 12, 2018 the company also continues to make great progress with tfc-1067 and have scheduled follow-up meetings with leading… twitter.com/i/web/status/1… @sironabiochem july 12, 2018 sirona biochem announced that partner wanbang biopharmaceuticals has received approval for its sglt2 inhibitor to e… twitter.com/i/web/status/1… @sironabiochem july 5, 2018 recently, clarivate analytics released their 2018 drugs to watch report and included sirona's sglt-2 inhibitor tfc-… twitter.com/i/web/status/1… news events privacy policy terms of use copyright 2011 © sirona biochem. metro web systems --

Analyse PopURL pour tfchemistry.com

http://www.sironabiochem.com/media-investors/news-2/tfchem-news-fr/
http://www.sironabiochem.com/about-tfchem/about-tfchem-2/#tab-tabber_widget-4-2
http://www.sironabiochem.com/about-tfchem/about-tfchem-2/#tab-tabber_widget-4-3
http://www.sironabiochem.com/about-tfchem/about-tfchem-2/#tab-tabber_widget-4-1
http://www.sironabiochem.com/about-sirona/board-of-directors/
http://www.sironabiochem.com/media-investors/2017-proxy-documents/
http://www.sironabiochem.com/sirona-biochem-attend-2017-bio-international-conference-san-diego-june-19-22/
http://www.sironabiochem.com/about-tfchem/about-tfchem-2/products/pipeline
http://www.sironabiochem.com/sirona-annual-general-meetingdecember-18-2017vancouver-bc/
http://www.sironabiochem.com/sirona-biochem-announces-chief-scientific-officer-present-adaptations-polar-environments-biomimicry/
http://www.sironabiochem.com/about-tfchem/laboratory-capabilities/
http://www.sironabiochem.com/sirona-biochem-announces-cfda-approval-of-sglt2-inhibitor-for-phase-i-clinical-trial/
http://www.sironabiochem.com/about-tfchem/about-tfchem-2/products/proprietary-platform/
http://www.sironabiochem.com/about-sirona/scientific-advisory-board/
http://www.sironabiochem.com/sirona-biochem-to-exhibit-at-the-shanghai-china-beauty-expo-2018/

Informations Whois

Whois est un protocole qui permet d'accéder aux informations d'enregistrement.Vous pouvez atteindre quand le site Web a été enregistré, quand il va expirer, quelles sont les coordonnées du site avec les informations suivantes. En un mot, il comprend ces informations;

Domain Name: TFCHEMISTRY.COM
Registry Domain ID: 1352202545_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.namebay.com
Registrar URL: http://www.namebay.com
Updated Date: 2016-10-28T09:40:30Z
Creation Date: 2007-12-10T14:34:44Z
Registry Expiry Date: 2017-12-10T14:34:44Z
Registrar: NAMEBAY
Registrar IANA ID: 88
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS1.HOST.FR
Name Server: NS2.HOST.FR
Name Server: NS3.HOST.FR
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-08-12T03:00:04Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR NAMEBAY

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =tfchemistry.com

  PORT 43

  TYPE domain
RegrInfo
DOMAIN

  NAME tfchemistry.com

  CHANGED 2016-10-28

  CREATED 2007-12-10

STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited

NSERVER

  NS1.HOST.FR 79.98.16.40

  NS2.HOST.FR 91.121.63.122

  NS3.HOST.FR 163.172.80.32

  REGISTERED yes

Erreurs

La liste suivante vous montre les fautes d'orthographe possibles des internautes pour le site Web recherché.